FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...